ArticleJournal of experimental orthopaedics2020
Correction to: Prolotherapy agent P2G is associated with upregulation of fibroblast growth factor-2 genetic expression in vitro.
Elisha Johnston et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.